vs

Side-by-side financial comparison of VIEMED HEALTHCARE, INC. (VMD) and WORLD ACCEPTANCE CORP (WRLD). Click either name above to swap in a different company.

WORLD ACCEPTANCE CORP is the larger business by last-quarter revenue ($141.3M vs $76.2M, roughly 1.9× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -0.6%, a 8.0% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 1.9%). WORLD ACCEPTANCE CORP produced more free cash flow last quarter ($57.2M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -5.8%).

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

Credit Acceptance Corporation is an auto finance company providing automobile loans and other related financial products. The company operates its financial program through a national network of dealer-partners, the automobile dealers participating in the programs. The company operates two programs: the "Portfolio Program" and the "Purchase Program". Through these programs, the company can advance money to automobile dealers in exchange for the right to service the underlying consumer loans a...

VMD vs WRLD — Head-to-Head

Bigger by revenue
WRLD
WRLD
1.9× larger
WRLD
$141.3M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+23.6% gap
VMD
25.5%
1.9%
WRLD
Higher net margin
VMD
VMD
8.0% more per $
VMD
7.4%
-0.6%
WRLD
More free cash flow
WRLD
WRLD
$47.5M more FCF
WRLD
$57.2M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
-5.8%
WRLD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
VMD
VMD
WRLD
WRLD
Revenue
$76.2M
$141.3M
Net Profit
$5.6M
$-911.3K
Gross Margin
57.9%
Operating Margin
11.0%
-0.7%
Net Margin
7.4%
-0.6%
Revenue YoY
25.5%
1.9%
Net Profit YoY
30.7%
-106.8%
EPS (diluted)
$0.14
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VMD
VMD
WRLD
WRLD
Q4 25
$76.2M
$141.3M
Q3 25
$71.9M
$134.5M
Q2 25
$63.1M
$132.5M
Q1 25
$59.1M
$165.3M
Q4 24
$60.7M
$138.6M
Q3 24
$58.0M
$131.4M
Q2 24
$55.0M
$129.5M
Q1 24
$50.6M
$159.3M
Net Profit
VMD
VMD
WRLD
WRLD
Q4 25
$5.6M
$-911.3K
Q3 25
$3.5M
$-1.9M
Q2 25
$3.2M
$1.3M
Q1 25
$2.6M
$44.3M
Q4 24
$4.3M
$13.4M
Q3 24
$3.9M
$22.1M
Q2 24
$1.5M
$9.9M
Q1 24
$1.6M
$35.1M
Gross Margin
VMD
VMD
WRLD
WRLD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
VMD
VMD
WRLD
WRLD
Q4 25
11.0%
-0.7%
Q3 25
7.8%
-1.3%
Q2 25
8.1%
1.5%
Q1 25
6.5%
33.3%
Q4 24
10.6%
11.6%
Q3 24
9.7%
21.3%
Q2 24
6.6%
10.0%
Q1 24
4.4%
29.3%
Net Margin
VMD
VMD
WRLD
WRLD
Q4 25
7.4%
-0.6%
Q3 25
4.9%
-1.4%
Q2 25
5.0%
1.0%
Q1 25
4.4%
26.8%
Q4 24
7.1%
9.7%
Q3 24
6.7%
16.8%
Q2 24
2.7%
7.7%
Q1 24
3.2%
22.0%
EPS (diluted)
VMD
VMD
WRLD
WRLD
Q4 25
$0.14
$-0.19
Q3 25
$0.09
$-0.38
Q2 25
$0.08
$0.25
Q1 25
$0.06
$8.07
Q4 24
$0.10
$2.45
Q3 24
$0.10
$3.99
Q2 24
$0.04
$1.79
Q1 24
$0.04
$6.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VMD
VMD
WRLD
WRLD
Cash + ST InvestmentsLiquidity on hand
$13.5M
$10.0M
Total DebtLower is stronger
$677.2M
Stockholders' EquityBook value
$141.5M
$351.6M
Total Assets
$199.2M
$1.1B
Debt / EquityLower = less leverage
1.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VMD
VMD
WRLD
WRLD
Q4 25
$13.5M
$10.0M
Q3 25
$11.1M
$14.9M
Q2 25
$20.0M
$8.1M
Q1 25
$10.2M
$4.7M
Q4 24
$17.5M
$10.3M
Q3 24
$11.3M
$9.7M
Q2 24
$8.8M
$11.1M
Q1 24
$7.3M
$5.2M
Total Debt
VMD
VMD
WRLD
WRLD
Q4 25
$677.2M
Q3 25
$584.6M
Q2 25
$472.5M
Q1 25
$447.9M
Q4 24
$561.2M
Q3 24
$506.6M
Q2 24
$494.7M
Q1 24
$498.4M
Stockholders' Equity
VMD
VMD
WRLD
WRLD
Q4 25
$141.5M
$351.6M
Q3 25
$133.6M
$365.6M
Q2 25
$139.7M
$427.9M
Q1 25
$134.8M
$439.5M
Q4 24
$131.4M
$428.2M
Q3 24
$125.0M
$417.5M
Q2 24
$119.4M
$422.6M
Q1 24
$116.3M
$424.4M
Total Assets
VMD
VMD
WRLD
WRLD
Q4 25
$199.2M
$1.1B
Q3 25
$202.4M
$1.1B
Q2 25
$184.6M
$1.0B
Q1 25
$178.1M
$1.0B
Q4 24
$177.1M
$1.1B
Q3 24
$169.5M
$1.0B
Q2 24
$163.9M
$1.0B
Q1 24
$154.9M
$1.1B
Debt / Equity
VMD
VMD
WRLD
WRLD
Q4 25
1.93×
Q3 25
1.60×
Q2 25
1.10×
Q1 25
1.02×
Q4 24
1.31×
Q3 24
1.21×
Q2 24
1.17×
Q1 24
1.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VMD
VMD
WRLD
WRLD
Operating Cash FlowLast quarter
$18.4M
$58.0M
Free Cash FlowOCF − Capex
$9.7M
$57.2M
FCF MarginFCF / Revenue
12.7%
40.5%
Capex IntensityCapex / Revenue
11.5%
0.6%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M
$412.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VMD
VMD
WRLD
WRLD
Q4 25
$18.4M
$58.0M
Q3 25
$18.4M
$48.6M
Q2 25
$12.3M
$58.2M
Q1 25
$2.9M
$254.2M
Q4 24
$15.0M
$61.1M
Q3 24
$12.7M
$53.8M
Q2 24
$10.2M
$48.4M
Q1 24
$1.2M
$265.8M
Free Cash Flow
VMD
VMD
WRLD
WRLD
Q4 25
$9.7M
$57.2M
Q3 25
$10.7M
$47.7M
Q2 25
$4.1M
$57.1M
Q1 25
$-12.6M
$250.5M
Q4 24
$3.2M
$60.4M
Q3 24
$1.7M
$52.7M
Q2 24
$1.2M
$47.3M
Q1 24
$-4.8M
$259.9M
FCF Margin
VMD
VMD
WRLD
WRLD
Q4 25
12.7%
40.5%
Q3 25
14.9%
35.5%
Q2 25
6.5%
43.1%
Q1 25
-21.4%
151.6%
Q4 24
5.2%
43.6%
Q3 24
3.0%
40.1%
Q2 24
2.3%
36.5%
Q1 24
-9.5%
163.2%
Capex Intensity
VMD
VMD
WRLD
WRLD
Q4 25
11.5%
0.6%
Q3 25
10.6%
0.7%
Q2 25
12.9%
0.8%
Q1 25
26.2%
2.2%
Q4 24
19.5%
0.5%
Q3 24
19.0%
0.8%
Q2 24
16.3%
0.8%
Q1 24
11.9%
3.7%
Cash Conversion
VMD
VMD
WRLD
WRLD
Q4 25
3.27×
Q3 25
5.23×
Q2 25
3.88×
43.27×
Q1 25
1.09×
5.74×
Q4 24
3.47×
4.56×
Q3 24
3.29×
2.43×
Q2 24
6.94×
4.87×
Q1 24
0.73×
7.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons